You are here

Leadership Team

Board of Directors of the CEO Roundtable on Cancer

Robert A. Bradway

Immediate Past Chairman, CEO Roundtable on Cancer
Chairman and Chief Executive Officer, Amgen

Scott White

Board Member, CEO Roundtable on Cancer
Company Group Chairman, North America Pharmaceuticals, Johnson & Johnson

Christopher A. Viehbacher

Past Chairman, CEO Roundtable on Cancer
Managing Partner, Gurnet Point Capital

Robert A. Ingram

Founding Chairman, CEO Roundtable on Cancer
General Partner, Hatteras Venture Partners

Kenneth B. Lee, Jr.

Interim Chief Executive Officer, CEO Roundtable on Cancer
Chairman of the Board, CEO Roundtable on Cancer

Peter WT Pisters, MD, MHCM

Board Member, CEO Roundtable on Cancer
President, University of Texas MD Anderson Cancer Center

Belén Garijo, MD

Board Member, CEO Roundtable on Cancer
Chair, Executive Board, and CEO, Merck KGaA, Darmstad, Germany

Emeritus Directors of the CEO Roundtable on Cancer

Martin J. Murphy, DMedSc, PhD, FASCO

Director Emeritus, CEO Roundtable On Cancer

William C. Weldon

Director Emeritus, CEO Roundtable on Cancer

CEO Roundtable on Cancer  Senior Leadership

William C. Louv, PhD

President, Project Data Sphere

Betty Whichard

Chief Financial Officer and Director of Finance and Human Resources, CEO Roundtable on Cancer and Project Data Sphere

MaryLisabeth Rich

President, CEO Roundtable on Cancer

Life Sciences Consortium Task Force Leadership

David M. Reese, MD

Co-Chair Life Sciences Consortium Task Force
Executive Vice President of Research & Development, Amgen

Mace Rothenberg, MD

Co-Chair, Life Sciences Consortium Task Force
Special Advisor, Pfizer

Roy D. Baynes, MD, PhD

Life Sciences Consortium Task Force Member
Senior Vice President, Global Clinical Development, and Chief Medical Officer, Merck Research Laboratories

Sean Khozin, MD, MPH

Life Sciences Consortium Task Force Member
Chief Executive Officer, CancerLinQ

Maria Rivas, MD

Life Sciences Consortium Task Force Member
Chief Medical Officer, Merck KGaA, Darmstadt, Germany

Craig L. Tendler, MD

Life Sciences Consortium Task Force Member
Vice President, Clinical Development and Global Medical Affairs, Oncology, Janssen Research & Development, LLC

CEO Cancer Gold Standard™  Task Force Leadership

David Shepperly, MD, MHS, FACOEM

Co-Chair, CEO Cancer Gold Standard™ Task Force
Executive Director Occupational Health, Bristol-Myers Squibb

Marcelo C. Targino, MD, MPH

Co-Chair, CEO Cancer Gold Standard™ Task Force
Chief Health Officer and Corporate Medical Director, Johnson & Johnson

L. Michelle Bennett, Ph.D.

Gold Standard Task Force, Member
Director, Center for Research Strategy, National Cancer Institute
Chief Innovation Officer (Acting), National Institute of Environmental Health Sciences

Otis W. Brawley, MD, MACP

Gold Standard Task Force, Member
Bloomberg Distinguished Professor, Johns Hopkins University

Ron Z. Goetzel, PhD

Gold Standard Task Force, Member
Senior Scientist And Director, Institute for Health and Productivity Studies, Johns Hopkins Bloomberg School of Public Health